5AM Ventures is a Boston, Massachusetts, United States–based early-stage venture capital firm that specializes in life sciences and biotechnology investments, providing seed through Series B capital to companies developing novel therapeutics, medical technologies and platform science innovations; it partners with scientific founders and research institutions to help advance early discoveries toward clinical and commercial milestones, drawing on sector expertise and operational support to guide portfolio companies through regulatory, technical and growth challenges.